Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BYON-4413 by Byondis for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
BYON-4413 is under clinical development by Byondis and currently in Phase I for Relapsed Acute Myeloid Leukemia. According to GlobalData,...
BYON-4413 by Byondis for Refractory Acute Myeloid Leukemia: Likelihood of Approval
BYON-4413 is under clinical development by Byondis and currently in Phase I for Refractory Acute Myeloid Leukemia. According to GlobalData,...
BYON-4413 by Byondis for Myelodysplastic Syndrome: Likelihood of Approval
BYON-4413 is under clinical development by Byondis and currently in Phase I for Myelodysplastic Syndrome. According to GlobalData, Phase I...